Correlation Between Neurocrine Biosciences and United Amern

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and United Amern at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and United Amern into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and United Amern Pete, you can compare the effects of market volatilities on Neurocrine Biosciences and United Amern and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of United Amern. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and United Amern.

Diversification Opportunities for Neurocrine Biosciences and United Amern

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neurocrine and United is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and United Amern Pete in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Amern Pete and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with United Amern. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Amern Pete has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and United Amern go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and United Amern

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.7 times less return on investment than United Amern. But when comparing it to its historical volatility, Neurocrine Biosciences is 8.45 times less risky than United Amern. It trades about 0.13 of its potential returns per unit of risk. United Amern Pete is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.10  in United Amern Pete on September 22, 2024 and sell it today you would lose (0.03) from holding United Amern Pete or give up 30.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  United Amern Pete

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
United Amern Pete 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in United Amern Pete are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, United Amern exhibited solid returns over the last few months and may actually be approaching a breakup point.

Neurocrine Biosciences and United Amern Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and United Amern

The main advantage of trading using opposite Neurocrine Biosciences and United Amern positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, United Amern can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Amern will offset losses from the drop in United Amern's long position.
The idea behind Neurocrine Biosciences and United Amern Pete pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets